20 March, 2020

COVID-19 - Continuity of our operations

We understand that you may be concerned regarding the impact of the current COVID-19 outbreak on our operations.

We want to reassure you that Trans-Hit Bio is committed to providing our services to enable the continuation of your research.

The situation surrounding COVID-19 is fast moving, and Trans-Hit Bio is doing everything that we can to maintain the procurement of biospecimens during this unprecedented time.

Trans-Hit Bio’s team will continue its work in supporting the global research community in diagnosing and preventing devastating illnesses like COVID-19. Our employees are working from home in order to ensure the continuity of our operations.

We are working closely with our worldwide Biospecimen Provider Partners and shipment services to avoid any delays. However, there may be some unavoidable impact that are beyond our control. We will do our best to try to resolve any such impact.

We are continuously monitoring government announcements worldwide and guidance as the situations develop.

If you have any further questions, please do not hesitate to get in touch with us at [email protected].